MM-121

Merrimack cuts 60% of jobs, narrows R&D focus
Biopharma Dive
Wed, 11/7/18 - 10:36 pm
Merrimack Pharmaceuticals
layoffs
R&D
MM-121
Merrimack Pharma’s stock plunges (again) on its latest cancer drug trial flop
Endpoints
Fri, 10/19/18 - 09:40 am
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights
Yahoo/Zacks.com
Mon, 06/23/14 - 07:52 pm
Sanofi
Merrimack Pharmaceuticals
MM-121
Merrimack - Not Bad News?
Seeking Alpha
Thu, 10/31/13 - 08:52 am
Merrimack Pharmaceuticals
MM-121
ovarian cancer
Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
The Fly on the Wall
Thu, 05/23/13 - 09:44 am
Merrimack Pharmaceuticals
MM-121
breast cancer
Merrimack lung cancer drug fails goal in one mid-stage trial group
Reuters
Thu, 04/4/13 - 09:22 am
lung cancer
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
3 Things to Watch at Merrimack
Motley Fool
Sun, 12/30/12 - 12:12 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
MM-121
breast cancer
lung cancer
IPO Preview: Merrimack Pharmaceuticals
Seeking Alpha
Mon, 01/30/12 - 03:51 pm
IPOs
Merrimack Pharmaceuticals
cancer
Sanofi
MM-121